Is AbbVie Stock Halal?
AbbVie Inc. · ABBV · NYSE
AbbVie Inc. (ABBV) passes our AAOIFI-based screen. Its core business is permissible, and (data as of 2026-03-31) interest-bearing debt is 18.1% of market cap and cash plus interest-bearing securities 2.3% — both inside the 30% AAOIFI thresholds. Ratios move with the share price, so check the data-as-of date; any incidental interest income should be purified.
Financial data as of 2026-03-31 · Screening basis: AAOIFI · Last reviewed 2026-06-15
Our Analysis
AbbVie is a large research-based biopharmaceutical company best known for its immunology franchise — Skyrizi and Rinvoq, which succeeded the former mega-seller Humira — plus oncology, neuroscience, eye care, and the aesthetics business that includes Botox. Developing and selling prescription medicines is a permissible healthcare activity with no prohibited revenue lines, and Zoya classifies ABBV as Shariah-compliant.
On the financials, AbbVie took on significant debt for past acquisitions, but relative to its large market value the debt-to-market-cap ratio sits around 18% — under the 30% AAOIFI limit — and interest income is only about 0.4% of revenue. That keeps it inside both financial screens, with routine dividend purification for the small interest share.
The practical takeaway: ABBV clears the business screen and currently passes the financial ratios, though its debt load is worth monitoring more closely than a debt-light peer — a sharp drop in market cap could push the debt ratio toward the limit. Re-check after new filings and avoid leverage on the position.
Business Activity Screen
AbbVie is a research-based biopharmaceutical company. Its portfolio spans immunology (Skyrizi, Rinvoq, formerly Humira), oncology, neuroscience, eye care, and aesthetics (Botox). Revenue is from developing, manufacturing, and selling prescription medicines — a permissible healthcare activity.
No alcohol, gambling, tobacco, or conventional-finance revenue is disclosed. Our screen shows debt-to-market-cap ~18% and interest income ~0.4% of revenue, both under AAOIFI thresholds. Modest dividend purification applies for the small interest component.
Financial Ratio Screen
| Screen | Value | AAOIFI limit | Result |
|---|---|---|---|
| Interest-bearing debt / market cap | 18.1% | < 30% | Pass |
| Cash + interest-bearing securities / market cap | 2.3% | < 30% | Pass |
| Impermissible income / total revenueInterest income $266.0M on $61.16B total revenue (AbbVie Inc. FY2025 (fiscal year ended 2025-12-31, Form 10-K)) = 0.4% — under AAOIFI's 5% limit. | 0.4% | < 5% | Pass |
Spot market cap at research date (consider trailing average for borderline names). Data as of 2026-03-31 · thresholds per AAOIFI Shariah standards.
This verdict uses the AAOIFI standard — the most widely used and, at a 30% debt limit, the most conservative mainstream Shariah standard. Interest-bearing debt and interest-bearing securities each stay under 30% of market cap, and impermissible income under 5% of revenue. Other standards (Dow Jones Islamic, S&P Shariah, MSCI Islamic, FTSE Yasaar) use ~33% limits or screen against total assets, so a borderline company can be rated differently by each. How we screen & why screeners disagree →
How AbbVie screens across Shariah standards
The standards disagree on this company. It passes some Shariah screens and fails others — which is exactly why you may see a different answer in different apps. Our headline verdict uses AAOIFI, the strictest and most widely cited mainstream standard.
| Standard | Debt | Cash & interest securities | Limit / basis | Result |
|---|---|---|---|---|
| AAOIFI (our standard) | 18.1% | 2.3% | < 30% of market cap | Pass |
| Dow Jones Islamic / S&P Shariah thresholdDow Jones and S&P apply this limit against a trailing 24–36-month average market cap; shown here on the same point-in-time market cap for comparison. | 18.1% | 2.3% | < 33% of market cap | Pass |
| MSCI Islamic / FTSE Yasaar basisTotal-assets denominator. MSCI/FTSE also apply entry/exit buffers and a receivables screen we do not reproduce. | 53.4% | 6.9% | < 33.33% of total assets | Fail |
HalalWallet computation reproducing each standard's threshold and denominator from public filings (balance sheet as of 2026-03-31) — not the providers' licensed index determinations, which can differ. Debt is interest-bearing borrowings (operating leases excluded). The impermissible-income screen (< 5% of revenue) is common to all of these standards and is shown in the ratio table above. Dow Jones and S&P apply their limit against a trailing 24–36-month average market cap; MSCI and FTSE add entry/exit buffers and a receivables screen. Full methodology →
Other stocks where Shariah screeners disagree
These companies pass under some mainstream standards and fail under others — the same pattern as this verdict. That is why two apps can show different answers.
AirbnbABNB
Passes market-cap screens · fails MSCI/FTSE (total assets)
AmgenAMGN
Passes market-cap screens · fails MSCI/FTSE (total assets)
Arista NetworksANET
Passes market-cap screens · fails MSCI/FTSE (total assets)
ArmARM
Passes market-cap screens · fails MSCI/FTSE (total assets)
BlockXYZ
Fails AAOIFI market-cap · passes MSCI/FTSE (total assets)
BP p.l.c.BP
Fails AAOIFI market-cap · passes MSCI/FTSE (total assets)
Scholars' & Screeners' Positions
Published positions, cited as stated. Screeners can reach different conclusions on the same company because of ratio timing and methodology differences — we report the disagreement rather than flatten it.
Purification
Even Shariah-compliant companies typically earn a small amount of incidental interest on corporate cash. The standard practice is to purify: donate the proportion of your dividends (and, per some scholars, capital gains) attributable to impermissible income. Our purification calculator automates the math from your holding and the company's disclosed figures.
Purification calculatorKeep your portfolio halal
A pass today isn't a pass forever — ratios drift across thresholds between filings. A halal screener monitors holdings continuously.
Related guides
Consider Consulting an Islamic Scholar
Major whether AbbVie Inc. is halal decisions often involve nuances that vary by scholarly opinion and personal circumstance. While HalalWallet provides educational comparisons and tools, we are not scholars or financial advisors. For personal guidance on Shariah compliance, consider speaking with a qualified Islamic scholar, your local imam, or a Shariah-certified financial advisor familiar with your situation.
Important: HalalWallet is an educational comparison platform. We do not provide financial, legal, or religious advice.
Product structures and Shariah-compliance oversight vary by provider. Before applying:
- Verify halal compliance directly with the provider.
- Review the contract structure (Murabaha, Ijara, Musharakah, etc.) and any disclosed Shariah board opinions.
- Consult a qualified Islamic finance advisor or scholar for guidance on your individual circumstances.
Frequently Asked Questions
Sources and review process
This page is reviewed against HalalWallet editorial standards and source documentation.
Reviewed by: HalalWallet Editorial Team
Last reviewed: 2026-06-01
How to cite this page
Preferred format:
For time-sensitive claims (rates, fees, state availability), please verify directly with the provider's official documentation and note the retrieval date.
Editorial Team, HalalWallet
Independent halal finance research
Reviewed quarterly and updated for major content changes.